Shannon M. Rego

This study integrates metabolomics and proteomics data from NGLY1 deficiency patient samples and cellular models to identify molecular phenotypes linked to immune activation and metabolic disturbances.

The paper assesses exome sequencing in a healthy cohort to determine the frequency of medically actionable and non-actionable findings, finding 17% had actionable variants, including some outside standard guidelines.